Identification of Epigenetically Inactivated Genes in Human Hepatocellular Carcinoma by Integrative Analyses of Methylation Profiling and Pharmacological Unmasking

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Digestive Diseases

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000368015PMID 25376292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The metastatic microenvironment: Claudin‐1 suppresses the malignant phenotype of melanoma brain metastasis

  2015cited by this paper
• Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications

  2014cited by this paper
• Drug Therapy for Advanced-Stage Liver Cancer

  2014cited by this paper
• Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.

  2014cited by this paper
• Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

  2013cited by this paper
• From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence

  2013cited by this paper
• Recent Advancements in Comprehensive Genetic Analyses for Human Hepatocellular Carcinoma

  2013cited by this paper
• From Cirrhosis to Hepatocellular Carcinoma : New Molecular Insights on Inflammation and Cellular Senescence

  2013cited by this paper
• Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

  2013cited by this paper
• Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer

  2013cited by this paper
• Oxidative Stress and Epigenetic Instability in Human Hepatocarcinogenesis

  2013cited by this paper
• Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.

  2013cited by this paper
• Epidemiology and Surveillance of Hepatocellular Carcinoma

  2012cited by this paper
• Integrative Array-Based Approach Identifies MZB1 as a Frequently Methylated Putative Tumor Suppressor in Hepatocellular Carcinoma

  2012cited by this paper
• Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma

  2012cited by this paper
• Emerging Signaling Pathways in Hepatocellular Carcinoma

  2012cited by this paper
• Genome‐wide DNA methylation profiles in hepatocellular carcinoma

  2012cited by this paper
• Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors

  2012cited by this paper
• Stem Cell Gene SALL4 Suppresses Transcription through Recruitment of DNA Methyltransferases*

  2011cited by this paper
• Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review

  2011cited by this paper
• Molecular analysis of gastric differentiated‐type intramucosal and submucosal cancers

  2010cited by this paper
• Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.

  2010cited by this paper
• Identification of Methylated Genes Associated with Aggressive Bladder Cancer

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.

  2009cited by this paper
• EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

  2009cited by this paper
• Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.

  2007cited by this paper
• Expression of p57KIP2 in hepatocellular carcinoma: relationship between tumor differentiation and patient survival

  2002cited by this paper
• Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.

  2002cited by this paper

• Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma

  2024cites this paper
• Transcriptome profiles associated with selenium-deficiency-dependent oxidative stress identify potential diagnostic and therapeutic targets in liver cancer cells

  2021cites this paper
• Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy

  2018cites this paper
• Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis

  2018cites this paper
• Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.

  2018cites this paper
• New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017

  2017cites this paper
• Role of Immune Checkpoint Blockade in the Treatment for Human Hepatocellular Carcinoma

  2017cites this paper
• Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma

  2017cites this paper
• Liver Cancer in Japan - State of the Art

  2016cites this paper
• Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations

  2016cites this paper
• Salivary Gland Neoplasms.

  2016cites this paper
• Analysis of DNA Methylation in Plasma for Monitoring Hepatocarcinogenesis

  2015influential citation
• Advances in the Management of Hepatocellular Cancer

  2015cites this paper
• Hepatic DNA Methylation Is Affected by Hepatocellular Carcinoma Risk in Patients with and without Hepatitis Virus

  2015cites this paper